Home
Clinical Resources Search
PQI: Elranatamab (Elrexfio®) for the treatment of Relapsed/Refractory Multiple Myeloma

Elranatamab (Elrexfio®) for the treatment of Relapsed/Refractory Multiple Myeloma

About this PQI

The purpose of this PQI is to discuss clinical considerations around using elranatamab (Elrexfio®) to optimize the outcomes for patients with treatment of relapsed/refractory multiple myeloma (RRMM).

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Hematological Malignancies Multiple Meloma (MM) Multiple Myeloma Elranatamab Elrexfio Orserdu

PQI

Frequently Searched

Supported by

Elranatamab (Elrexfio®) for the treatment of Relapsed/Refractory Multiple Myeloma

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia

PQI: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC

PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer

PQI in Action: Abiraterone acetate (Yonsa®) Patient Selection and Management

PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma

PQI in Action: Fruquintinib (Fruzaqla®)

PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2

S9 E5: Global Health, Cancer Survivorship, and Advancing Equity

S9 E4: Advancing Pharmacogenomics in Oncology

S9 E3: Firefighter Health & Cancer Prevention

S9 E2: Love Languages in Cancer Care

Readiness Tracker

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

S7 Ep 8: Sickle Cell Disease Insights

PQI: Selinexor (Xpovio®) Patient Management

PQI: Ixazomib (Ninlaro®) In the Treatment of Multiple Myeloma

PQI: Isatuximab-irfc (Sarclisa®) Regimens in 1q21 gain/amplification Relapsed/ Refractory Multiple Myeloma

PQI: Isatuximab-irfc (Sarclisa®) In Patients with Relapsed/Refractory Multiple Myeloma

PQI in Action: Isatuximab-irfc (Sarclisa®) in 1q21 Gain or Amplifications in Relapsed/Refractory Multiple Myeloma

PQI in Action: ClonoSEQ® Next Generation Sequencing for Minimal Residual Disease Testing in Multiple Myeloma